A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I-IIIA (1988) uterine papillary serous carcinoma of the endometrium. (Q36737086)

From Wikidata

Jump to navigation Jump to search

scientific article published on 4 February 2013

Language	Label	Description	Also known as
English	A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I-IIIA (1988) uterine papillary serous carcinoma of the endometrium.	scientific article published on 4 February 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23385150%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I-IIIA (1988) uterine papillary serous carcinoma of the endometrium (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23385150%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

chemoradiotherapy

0 references

1 reference

based on heuristic

inferred from title

serous carcinoma

1 reference

based on heuristic

inferred from title

Diane C. Bodurka

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23385150%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Lawrence B Levy

6

object named as

Lawrence B Levy

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23385150%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

9

object named as

Karen H Lu

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23385150%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Brian Slomovitz

4

object named as

Brian M Slomovitz

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23385150%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Anuja Jhingran

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23385150%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Lois M Ramondetta

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23385150%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Jubilee Brown

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23385150%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Michael E Garcia

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23385150%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Patricia J Eifel

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23385150%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Thomas W Burke

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23385150%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

language of work or name

0 references

publication date

4 February 2013

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23385150%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Gynecologic Oncology

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23385150%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

129

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23385150%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23385150%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

304-309

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23385150%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4810787

29 September 2017

Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4810787

29 September 2017

The role of abdominal-pelvic radiotherapy in the management of uterine papillary serous carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4810787

29 September 2017

Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4810787

29 September 2017

Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4810787

29 September 2017

Treatment of uterine papillary serous carcinoma with paclitaxel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4810787

29 September 2017

Phase I Trial of Taxol as a Radiation Sensitizer with Cisplatin in Advanced Cervical Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4810787

29 September 2017

Weekly paclitaxel with and without concurrent radiation therapy: toxicity, pharmacokinetics, and response.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4810787

29 September 2017

Uterine papillary serous carcinoma treated with intraperitoneal cisplatin and intravenous doxorubicin and cyclophosphamide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4810787

29 September 2017

Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4810787

28 June 2018

Revised FIGO staging for gynaecological cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4810787

28 June 2018

Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4810787

28 June 2018

Taxol: a novel radiation sensitizer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4810787

28 June 2018

Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4810787

5 September 2018

Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4810787

5 September 2018

Effective Treatment of Stage I Uterine Papillary Serous Carcinoma with High Dose-Rate Vaginal Apex Radiation (192Ir) and Chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4810787

5 September 2018

The importance of chemotherapy and radiation in uterine papillary serous carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4810787

4 December 2018

Improved outcome at 10 years for serous-papillary/clear cell or high-risk endometrial cancer patients treated by adjuvant high-dose whole abdomino-pelvic irradiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.025

7 January 2021

Intravenous cisplatin, doxorubicin, and cyclophosphamide in the treatment of uterine papillary serous carcinoma (UPSC)

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.025

7 January 2021

The use of paclitaxel and platinum-based chemotherapy in uterine papillary serous carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.025

7 January 2021

In vitro studies of Taxol as a radiation sensitizer in human tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.025

7 January 2021

Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.025

7 January 2021

Paclitaxel and concurrent radiation for locally advanced pancreatic and gastric cancer: a phase I study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.025

7 January 2021

IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with post-operative adjuvant or salvage radiotherapy after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.025

7 January 2021

Clinical outcome with adjuvant treatment of endometrial carcinoma using intensity-modulated radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.025

7 January 2021

Adjuvant concurrent chemoradiotherapy with intensity-modulated pelvic radiotherapy after surgery for high-risk, early stage cervical cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.025

7 January 2021

Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.025

7 January 2021

Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.025

7 January 2021

A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.025

7 January 2021

Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.025

7 January 2021

High-dose rate brachytherapy for Stage I/II papillary serous or clear cell endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.025

7 January 2021

Identifiers

10.1016/J.YGYNO.2013.01.025

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23385150%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23385150%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23385150%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36737086&oldid=2034420620"